• Issue

    Liver International: Volume 39, Issue 3

    411-591
    March 2019
Previous Issue|Next Issue
Export Citation(s)Download PDF(s)

ISSUE INFORMATION

Free Access

Issue Information

  • Pages: 411-415
  • First Published: 21 February 2019

REVIEWS

Free Access

Hepatitis C: Is eradication possible?

Andrea Lombardi,  Mario U. Mondelli,  ESCMID Study Group for Viral Hepatitis (ESGVH) , 
  • Pages: 416-426
  • First Published: 25 November 2018
Free Access

Oleanolic acid reprograms the liver to protect against hepatotoxicants, but is hepatotoxic at high doses

Jie Liu,  Yuan-Fu Lu,  Qin Wu,  Shang-Fu Xu,  Fu-Guo Shi,  Curtis D. Klaassen, 
  • Pages: 427-439
  • First Published: 06 August 2018

EDITORIALS

Free Access

Insights into paediatric non-alcoholic fatty liver disease from genetic variants

Jiawen Dong,  Yu Ri Im,  Jake P. Mann, 
  • Pages: 440-445
  • First Published: 07 January 2019

See Article on Page 540

Free Access

Direct-acting antivirals and the risk of hepatocellular carcinoma: The end of a polemic?

Stanislas Pol,  Anaïs Vallet-Pichard,  Hélène Fontaine,  Fabrice Carrat, 
  • Pages: 446-447
  • First Published: 21 February 2019

See Article on Page 448

VIRAL HEPATITIS

The impact of HCV eradication by direct-acting antivirals on the transition of precancerous hepatic nodules to HCC: A prospective observational study

Hidenori Toyoda,  Takashi Kumada,  Toshifumi Tada,  Kazuyuki Mizuno,  Yasuhiro Sone,  Tomoyuki Akita,  Junko Tanaka,  Philip J. Johnson, 
  • Pages: 448-454
  • First Published: 12 October 2018

See Editorial on Page 446

REtrieval And cure of Chronic Hepatitis C (REACH): Results of micro-elimination in the Utrecht province

Patricia A. M. Kracht,  Joop E. Arends,  Karel J. van Erpecum,  Steven F. T. Thijsen,  Bart J. M. Vlaminckx,  Annemarie J. L. Weersink,  Anne M. J. Wensing,  Marjolein P. H. Deege,  Marieke Dimmendaal,  Paul H. G. M. Stadhouders,  Philip W. Friederich,  Marc A. M. T. Verhagen,  Greet J. Boland,  Andy I. M. Hoepelman, 
  • Pages: 455-462
  • First Published: 11 September 2018
Open Access

SNP rs688 within the low-density lipoprotein receptor (LDL-R) gene associates with HCV susceptibility

Gaby S. Steba,  Sylvie M. Koekkoek,  Michael W. T. Tanck,  Joost W. Vanhommerig,  Jan T. M. van der Meer,  David Kwa,  Kees Brinkman,  Maria Prins,  Ben Berkhout,  Georgios Pollakis,  Richard Molenkamp,  Janke Schinkel,  William A. Paxton, on behalf of the MOSAIC (MSM observational Study of Acute infection with Hepatitis C) Study Group and the ACS (Amsterdam Cohort Studies) , 
  • Pages: 463-469
  • First Published: 27 September 2018

Liver decompensation in HIV/Hepatitis B coinfection in the combination antiretroviral therapy era does not seem increased compared to hepatitis B mono-infection

Faydra I. Lieveld,  Colette Smit,  Clemens Richter,  Karel J. van Erpecum,  Bernhard W. M. Spanier,  Elisabeth H. Gisolf,  Jan M. Vrolijk,  Peter D. Siersema,  Andy I. M. Hoepelman,  Peter Reiss,  Joop E. Arends, 
  • Pages: 470-483
  • First Published: 09 November 2018

Effectiveness and safety of switching to entecavir hepatitis B patients developing kidney dysfunction during tenofovir

Mauro Viganò,  Alessandro Loglio,  Sara Labanca,  Serena Zaltron,  Francesco Castelli,  Pietro Andreone,  Vincenzo Messina,  Roberto Ganga,  Nicola Coppola,  Aldo Marrone,  Maurizio Russello,  Alfredo Marzano,  Alessandra Tucci,  Gloria Taliani,  Massimo Fasano,  Stefano Fagiuoli,  Erica Villa,  Fabrizio Bronte,  Teresa Santantonio,  Giuseppina Brancaccio,  Vincenzo Occhipinti,  Floriana Facchetti,  Glenda Grossi,  Mariagrazia Rumi,  Pietro Lampertico, 
  • Pages: 484-493
  • First Published: 07 December 2018

Clinical outcomes and management of patients with chronic hepatitis B and liver stiffness measurement in the grey zone

Ken Liu,  Vincent W. S. Wong,  Lilian Y. Liang,  Grace C. Y. Lui,  Henry L. Y. Chan,  Grace L. H. Wong, 
  • Pages: 494-502
  • First Published: 12 November 2018

CIRRHOSIS AND LIVER FAILURE

Invasive fungal infections amongst patients with acute-on-chronic liver failure at high risk for fungal infections

Nipun Verma,  Shreya Singh,  Sunil Taneja,  Ajay Duseja,  Virendra Singh,  Radha K. Dhiman,  Arunaloke Chakrabarti,  Yogesh K. Chawla, 
  • Pages: 503-513
  • First Published: 01 October 2018

Effect of proton pump inhibitors on the risk and prognosis of infections in patients with cirrhosis and ascites

Gitte Dam,  Hendrik Vilstrup,  Per Kragh Andersen,  Lars Bossen,  Hugh Watson,  Peter Jepsen, 
  • Pages: 514-521
  • First Published: 25 November 2018

CANCER

Hepatocellular carcinoma in Australia 1982-2014: Increasing incidence and improving survival

Michael C. Wallace,  David B. Preen,  Mark W. Short,  Leon A. Adams,  Gary P. Jeffrey, 
  • Pages: 522-530
  • First Published: 19 September 2018

Metabolic factors affecting hepatocellular carcinoma in steatohepatitis

Ali Zarrinpar,  Claire M. Faltermeier,  Vatche G. Agopian,  Bita V. Naini,  Michael P. Harlander-Locke,  Fady M. Kaldas,  Douglas G. Farmer,  Ronald W. Busuttil, 
  • Pages: 531-539
  • First Published: 14 November 2018

METABOLIC LIVER DISEASE

Genetic determinants of steatosis and fibrosis progression in paediatric non-alcoholic fatty liver disease

Christian A. Hudert,  Silvia Selinski,  Birgit Rudolph,  Hendrik Bläker,  Christoph Loddenkemper,  Ria Thielhorn,  Nikolaus Berndt,  Klaus Golka,  Cristina Cadenas,  Jörg Reinders,  Stephan Henning,  Philip Bufler,  Peter L. M. Jansen,  Hermann-Georg Holzhütter,  David Meierhofer,  Jan G. Hengstler,  Susanna Wiegand, 
  • Pages: 540-556
  • First Published: 16 November 2018

See Editorial on Page 440

Causality between non-alcoholic fatty liver disease and risk of cardiovascular disease and type 2 diabetes: A meta-analysis with bias analysis

Amy E. Morrison,  Francesco Zaccardi,  Kamlesh Khunti,  Melanie J. Davies, 
  • Pages: 557-567
  • First Published: 25 October 2018

Serum adipocyte fatty acid-binding protein levels: An indicator of non-alcoholic fatty liver disease in Chinese individuals

Yiting Xu,  Xiaojing Ma,  Xiaoping Pan,  Xingxing He,  Yufei Wang,  Yuqian Bao, 
  • Pages: 568-574
  • First Published: 16 December 2018

MISCELLANEOUS

Severity in polycystic liver disease is associated with aetiology and female gender: Results of the International PLD Registry

René M. M. van Aerts,  Wietske Kievit,  Michiel E. de Jong,  Curie Ahn,  Jesús M. Bañales,  Jana Reiterová,  Frederik Nevens,  Joost P. H. Drenth, 
  • Pages: 575-582
  • First Published: 17 September 2018

Periodontitis is associated with incident chronic liver disease—A population-based cohort study

Jaana Helenius-Hietala,  Anna Liisa Suominen,  Hellevi Ruokonen,  Matti Knuuttila,  Pauli Puukka,  Antti Jula,  Jukka H. Meurman,  Fredrik Åberg, 
  • Pages: 583-591
  • First Published: 09 October 2018